Suppr超能文献

噬菌体对感染了……的主动脉移植物的治疗

Phage treatment of an aortic graft infected with .

作者信息

Chan Benjamin K, Turner Paul E, Kim Samuel, Mojibian Hamid R, Elefteriades John A, Narayan Deepak

机构信息

Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA.

Program in Microbiology, Yale School of Medicine, New Haven, CT, USA.

出版信息

Evol Med Public Health. 2018 Mar 8;2018(1):60-66. doi: 10.1093/emph/eoy005. eCollection 2018.

Abstract

Management of prosthetic vascular graft infections caused by can be a significant challenge to clinicians. These infections often do not resolve with antibiotic therapy alone due to antibiotic resistance/tolerance by bacteria, poor ability of antibiotics to permeate/reduce biofilms and/or other factors. Bacteriophage OMKO1 binding to efflux pump proteins in was consistent with an evolutionary trade-off: wildtype bacteria were killed by phage whereas evolution of phage-resistance led to increased antibiotic sensitivity. However, phage clinical-use has not been demonstrated. Here, we present a case report detailing therapeutic application of phage OMKO1 to treat a chronic infection of an aortic Dacron graft with associated aorto-cutaneous fistula. Following a single application of phage OMKO1 and ceftazidime, the infection appeared to resolve with no signs of recurrence.

摘要

由[具体病因未提及]引起的人工血管移植物感染的管理对临床医生来说可能是一项重大挑战。由于细菌对抗生素的耐药性/耐受性、抗生素渗透/减少生物膜的能力差和/或其他因素,这些感染通常仅用抗生素治疗无法解决。噬菌体OMKO1与[细菌名称未提及]中的外排泵蛋白结合符合一种进化权衡:野生型细菌被噬菌体杀死,而噬菌体抗性的进化导致抗生素敏感性增加。然而,噬菌体的临床应用尚未得到证实。在这里,我们报告一例详细病例,讲述了噬菌体OMKO1治疗主动脉涤纶移植物慢性[感染类型未提及]感染并伴有主动脉皮肤瘘的治疗应用。单次应用噬菌体OMKO1和头孢他啶后,感染似乎得到解决,没有复发迹象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dd1/5842392/c40a7eb657f5/eoy005f1p.jpg

相似文献

1
Phage treatment of an aortic graft infected with .
Evol Med Public Health. 2018 Mar 8;2018(1):60-66. doi: 10.1093/emph/eoy005. eCollection 2018.
2
Phage steering of antibiotic-resistance evolution in the bacterial pathogen, .
Evol Med Public Health. 2020 Jul 11;2020(1):148-157. doi: 10.1093/emph/eoaa026. eCollection 2020.
3
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.
Sci Rep. 2016 May 26;6:26717. doi: 10.1038/srep26717.
4
Arms race and fluctuating selection dynamics in Pseudomonas aeruginosa bacteria coevolving with phage OMKO1.
J Evol Biol. 2022 Nov;35(11):1475-1487. doi: 10.1111/jeb.14095. Epub 2022 Sep 27.
5
Case report: Analysis of phage therapy failure in a patient with a prosthetic vascular graft infection.
Front Med (Lausanne). 2023 May 19;10:1199657. doi: 10.3389/fmed.2023.1199657. eCollection 2023.
8
Decay and damage of therapeutic phage OMKO1 by environmental stressors.
PLoS One. 2022 Feb 23;17(2):e0263887. doi: 10.1371/journal.pone.0263887. eCollection 2022.
9
Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
Appl Environ Microbiol. 2016 Aug 15;82(17):5332-9. doi: 10.1128/AEM.01166-16. Print 2016 Sep 1.
10
Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):360-6. doi: 10.4103/0377-4929.42511.

引用本文的文献

1
Phage Therapy: Combating Evolution of Bacterial Resistance to Phages.
Viruses. 2025 Aug 8;17(8):1094. doi: 10.3390/v17081094.
3
Reconstructing the Antibiotic Pipeline: Natural Alternatives to Antibacterial Agents.
Biomolecules. 2025 Aug 18;15(8):1182. doi: 10.3390/biom15081182.
4
Temperate phages increase antibiotic effectiveness in a infection model.
mBio. 2025 Aug 18:e0162125. doi: 10.1128/mbio.01621-25.
6
Lytic bacteriophages as alternative to overcoming antibiotic-resistant biofilms formed by clinically significant bacteria.
Ther Adv Infect Dis. 2025 Jul 18;12:20499361251356057. doi: 10.1177/20499361251356057. eCollection 2025 Jan-Dec.
7
Phages Exist as Episomal Pseudolysogens Across Diverse Soil Bacteria.
Microorganisms. 2025 May 28;13(6):1239. doi: 10.3390/microorganisms13061239.
8
Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United States.
Antibiotics (Basel). 2025 May 29;14(6):553. doi: 10.3390/antibiotics14060553.
9
Quantifying phage-bacteria dynamics rapid emergence of phage-resistant mutants for .
MicroPubl Biol. 2025 May 30;2025. doi: 10.17912/micropub.biology.001666. eCollection 2025.

本文引用的文献

3
Extending the lifetime of antibiotics: how can phage therapy help?
Future Microbiol. 2016 Sep;11:1105-7. doi: 10.2217/fmb-2016-0133. Epub 2016 Aug 22.
4
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.
Sci Rep. 2016 May 26;6:26717. doi: 10.1038/srep26717.
5
Anti-virulence Strategies to Target Bacterial Infections.
Curr Top Microbiol Immunol. 2016;398:147-183. doi: 10.1007/82_2015_490.
6
Ecology of Anti-Biofilm Agents I: Antibiotics versus Bacteriophages.
Pharmaceuticals (Basel). 2015 Sep 9;8(3):525-58. doi: 10.3390/ph8030525.
7
Multidisciplinary Treatment Approach for Prosthetic Vascular Graft Infection in the Thoracic Aortic Area.
Ann Thorac Cardiovasc Surg. 2015;21(5):418-27. doi: 10.5761/atcs.ra.15-00187. Epub 2015 Sep 8.
8
Bacteriophages and their enzymes in biofilm control.
Curr Pharm Des. 2015;21(1):85-99. doi: 10.2174/1381612820666140905112311.
9
The evolution of life history trade-offs in viruses.
Curr Opin Virol. 2014 Oct;8:79-84. doi: 10.1016/j.coviro.2014.07.005. Epub 2014 Aug 1.
10
Targeting virulence: can we make evolution-proof drugs?
Nat Rev Microbiol. 2014 Apr;12(4):300-8. doi: 10.1038/nrmicro3232.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验